References
- J.R. Warren and B.J. Marshall, Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (London, England), 1(8336), 1273–1275 (1983).
- T.L. Cover and M.J. Blaser, Helicobacter pylori in health and disease. Gastroenterology, 136(6), 1863–1873 (2009). doi:https://doi.org/10.1053/j.gastro.2009.01.073.
- T.L. Testerman and J. Morris, Beyond the stomach: an updated view of Helicobacter pylor pathogenesis, diagnosis, and treatment. World Journal of Gastroenterology, 20(36), 12781–12808 (2014). doi:https://doi.org/10.3748/wjg.v20.i36.12781.
- F. Megraud and P. Lehours, Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical Microbiology Reviews, 20(2), 280–322 (2007). doi:https://doi.org/10.1128/CMR.00033-06.
- M.N. Moghaddam, In vitro inhibition of Helicobacter pylori by some spices and medicinal plants used in Iran. Global Journal of Pharmacology, 5, 176–180 (2011).
- J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman and F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012. International Journal of Cancer, 136(5), E359–E386 (2015). doi:https://doi.org/10.1002/ijc.29210.
- B.V. Bonifácio, A.S. Ramos, P.B. Silva and M.B. Taís, Antimicrobial activity of natural products against Helicobacter pylori: a review. Annals of Clinical Microbiology and Antimicrobials, 13, 54 (2014). doi:https://doi.org/10.1186/s12941-014-0054-0.
- J. Molina-Infante and J.P. Gisbert, Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. World Journal of Gastroenterology, 20(30), 10338–10347 (2014). doi:https://doi.org/10.3748/wjg.v20.i30.10338.
- P.I. Hsu, D.C. Wu, W.C. Chen, H.H. Tseng, H.C. Yu, H.M. Wang, S.S. Kao, K.H. Lai, A. Chen and F.W. Tsay, Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. Antimicrobial Agents and Chemotherapy, 58(10), 5936–5942 (2014). doi:https://doi.org/10.1128/AAC.02922-14.
- B.V. Bonifácio, M.A. Dos Santos Ramos, P.B. Da Silva, et al., Antimicrobial activity of natural products against Helicobacter pylori: a review. Annals of Clinical Microbiology and Antimicrobials, 13(54), (2014).
- F.F. Vale and M. Oleastro, Overview of the phytomedicine approaches against Helicobacter pylori. World Journal of Gastroenterology, 20(19), 5594–5609 (2014). doi:https://doi.org/10.3748/wjg.v20.i19.5594.
- Y.C. Wang, Medicinal plant activity on Helicobacter pylori related diseases. World Journal of Gastroenterology, 20(30), 10368–10382 (2014). doi:https://doi.org/10.3748/wjg.v20.i30.10368.
- F. Bakkali, S. Averbeck, D. Averbeck and M. Idaomar, Biological effects of essential oils - a review. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 46(2), 446e47 (2008).
- J.H. Jeon, C.H. Lee and H.S. Lee, Food protective effect of geraniol and its congeners against stored food mites. Journal of Food Protection, 2(7), 1468e1471 (2009).
- K.I. de Carvalho, F. Bonamin, R.C. Dos Santos, et al., Geraniol- a flavoring agent with multifunctional effects in protecting the gastric and duodenal mucosa. Naunyn-Schmiedeberg’s Archives of Pharmacology, 387(4), 355e365 (2014). doi:https://doi.org/10.1007/s00210-013-0947-z.
- S. Sawada, J. Okano, R. Imamoto, et al., Preventive effect of geraniol on diethylnitrosamine-induced hepatocarcinogenesis in rats. Yonago Acta Medica, 59(1), 37e43 (2016).
- Z.A. Aziz, A. Ahmad, S.H.M. Setapar, A. Karakucuk, M.M. Azim, D. Lokhat, M. Rafatullah, M. Ganash, M.A. Kamal and G.M. Ashraf, Essential oils: extraction techniques, pharmaceutical and therapeutic potential - a review. Current Drug Metabolism, 19(13), 1100–1110 (2018). doi:https://doi.org/10.2174/1389200219666180723144850.
- T. Ohno, M. Kita, Y. Yamaoka, S. Imamura, T. Yamamoto, S. Mitsufuji, T. Kodoma, K. Kashima and J. Imanishi, Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter, 8(3), 207–215 (2003). doi:https://doi.org/10.1046/j.1523-5378.2003.00146.x.
- A. Deriu, G. Branca, P. Molicotti, G. Pintore, M. Chessa, B. Tirillini, B. Peglietti, A. Mura, L.A. Sechi, G. Fadda and S. Zanetti, In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori. International Journal of Antimicrobial Agents, 30(6), 562–563 (2007). doi:https://doi.org/10.1016/j.ijantimicag.2007.07.005.
- H. Gu, Role of Flagella in the pathogenesis of Helicobacter pylori. Current Microbiology, 74(7), 863–869 (2017). doi:https://doi.org/10.1007/s00284-017-1256-4.
- D.A. Bonsor, Q. Zhao, B. Schmidinger, E. Weiss, J. Wang, D. Deredge, R. Beadenkopf, B. Dow, W. Fischer, D. Beckett, et al., The Helicobacter pylori adhesin protein HopQ exploits the dimer interface of human CEACAMs to facilitate translocation of the oncoprotein, Cag.A. EMBO, J37, e98664 (2018).
- Q. Zhao, W. Yin, R. Zhao, Y. Wang, C. Song, H. Wang, J. Rong, F. Wang and Y. Xie, Outer inflammatory protein of Helicobacter pylori impacts IL-8 expression, adherence, cell apoptosis and cell cycle of gastric cells independent of its copy number. Medical Microbiology and Immunology, 209(5), 621–630 (2020). doi:https://doi.org/10.1007/s00430-020-00688-w.
- A.A. Hassan, A.I. Youssef, A.A. Ghazal, M.I. Sheta, N.L. Diwedar, E.M. Hafez, A.A. Tabll and E.Y. Elbendary, Blood group antigen binding Adhesion2 (BabA2) gene in gastric tissue biopsies as a diagnostic biomarker for Helicobacter pylori infection. Human Antibodies, 27(3), 193–199 (2019). doi:https://doi.org/10.3233/HAB-190372.
- J. Baj, A. Forma, M. Sitarz, P. Portincasa, G. Garruti, D. Krasowska and R. Maciejewski, Helicobacter pylori virulence factors— mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells, 10(1), 27 (2021). doi:https://doi.org/10.3390/cells10010027.
- G. Zanotti and L. Cendron, Structural aspects of helicobacter pylori antibiotic resistance. Advances in Experimental Medicine and Biology, 1149, 227–241 (2019).
- N. Wueppenhorst, H.P. Stueger, M. Kist and E. Glocker, Identification and molecular characterization of triple and quadruple-resistant Helicobacter pylori clinical isolates in Germany. Journal of Antimicrobial Chemotherapy, 63(4), 648–653 (2009). doi:https://doi.org/10.1093/jac/dkp003.
- I. Thung, H. Aramin, V. Vavinskaya, S. Gupta, J.Y. Park, S.E. Crowe and M.A. Valasek, Review article: the global emergence of Helicobacter pylori antibiotic resistance. Alimentary Pharmacology & Therapeutics, 43(4), 514–533 (2016). doi:https://doi.org/10.1111/apt.13497.
- Y. Shao, R. Lu, Y. Yang, Q. Xu, B. Wang and G. Ye, Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients. Journal of Clinical Laboratory Analysis, 32(4), e22339 (2018). doi:https://doi.org/10.1002/jcla.22339.
- V. De Francesco, F. Giorgio, C. Hassan, G. Manes, L. Vannella, C. Panella, E. Ierardi and A. Zullo, Worldwide H. pylori antibiotic resistance: a systematic review. Journal of Gastrointestinal and Liver diseases: JGLD, 19(4), 409–414 (2010).
- C. Bilgilier, A. Stadlmann, A. Makristathis, J. Thannesberger, M.T. Kastner, P. Knoflach, P. Steiner, et al., Austrian Helicobacter Study Group of the Austrian Society of Gastroenterology and Hepatology. Prospective multicenter clinical study on inter-and interpatient genetic variability for antimicrobial resistance of Helicobacter pylori. Clinical Microbiology and Infection, 24(3), 267–272 (2018). doi:https://doi.org/10.1016/j.cmi.2017.06.025.
- I.M. Saracino, A. Zullo, J. Holton, V. Castelli, G. Fiorini, C. Zaccaro, L. Ridola, C. Ricci, L. Gatta and D. Vaira, High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. Journal of Gastrointestinal and Liver diseases: JGLD, 21(4), 363–365 (2012).
- A. Cuadrado-Lavín, J.R. Salcines-Caviedes, M.F. Carrascosa, P. Mellado, I. Monteagudo, J. Llorca, M. Cobo, M.R. Campos, B. Ayestarán, A. Fernández-Pousa and E. González-Colominas, Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. Journal of Antimicrobial Chemotherapy, 67(1), 170–173 (2012). doi:https://doi.org/10.1093/jac/dkr410.
- L. Boyanova, J. Ilieva, G. Gergova, Z. Spassova, R. Nikolov, L. Davidkov, I. Evstatiev, V. Kamburov, N. Katsarov and I. Mitov, Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria. Journal of Medical Microbiology, 58(1), 94–100 (2009). doi:https://doi.org/10.1099/jmm.0.003855-0.
- S. Agudo, T. Alarcón, L. Cibrelus, P. Urruzuno, M.J. Martínez and M. López-Brea, High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Revista Espanola de Quimioterapia: Publicacion Oficial de La Sociedad Espanola de Quimioterapia, 22(2), 88–92 (2009).
- J.P. Gisbert, F. Bermejo, M. Castro-Fernández, A. Pérez-Aisa, M. Fernández-Bermejo, A. Tomas, J. Barrio, F. Bory, P. Almela, P. Sánchez-Pobre, et al., Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. The American Journal of Gastroenterology, 103(1), 71–76 (2008). doi:https://doi.org/10.1111/j.1572-0241.2007.01500.x.
- A.C. Ford, P. Malfertheiner, M. Giguere, J. Santana, M. Khan and P. Moayyedi, Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World Journal of Gastroenterology, 14(48), 7361–7370 (2008). doi:https://doi.org/10.3748/wjg.14.7361.
- A. Zullo, F. Perna, C. Hassan, C. Ricci, I. Saracino, S. Morini and D. Vaira, Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Alimentary Pharmacology & Therapeutics, 25(12), 1429–1434 (2007). doi:https://doi.org/10.1111/j.1365-2036.2007.03331.x.
- W.A. Shouny, S.S. Ali, H.M. Hegazy, M.K. Abd Elnabi, A. Asmaa and S. Jianzhong, Syzygium aromaticum L.: traditional herbal medicine against cagA and vacA toxin genes-producing drug-resistant Helicobacter pylori. Naunyn-Schmiedeberg’s Archives of Pharmacology, 10(4), 366–377 (2020). doi:https://doi.org/10.1016/j.jtcme.2019.05.002.
- M. Li, J. Wang and Z. Xu, Studied Chinese herbs on Helicobacter pylori. International Journal of Microbiology Reviews, 1, 6–10 (2013).
- S.D. Moghadam, S.D. Moghadam, F. Ebrahimi, M. Hayatbakhsh, M.J. Zahedi, M. Nazar, M. Hayatbakhsh, S. F and F. Sharififar, In vitro screening of selected Iranian medicinal plants against Helicobacter pylori. International Journal of Green Pharmacy, 5(4), 282–285 (2011). doi:https://doi.org/10.4103/0973-8258.94348.
- G.B. Mahady, S.L. Pendland, A. Stoia, F.A. Hamill, D. Fabricant, B.M. Dietz and L. R, Chadwick In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytotherapy Research, 19(11), 988–991 (2005). doi:https://doi.org/10.1002/ptr.1776.
- E. Yesilada, I. Gurbuz and H. Shibata, Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. Journal of Ethnopharmacology, 66(3), 289–293 (1999). doi:https://doi.org/10.1016/S0378-8741(98)00219-0.
- J.D. Cha, Y.H. Kim and J.Y. Kim, Essential oil and 1,8-cineole from Artemisia lavandulaefolia induces apoptosis in KB Cells via mitochondrial stress and caspase activation. Food Science and Biotechnology, 19(1), 1. 185–191 (2010). doi:https://doi.org/10.1007/s10068-010-0025-y.
- G.K. Jayaprakasha, K.N. Murthy, R.M. Uckoo and B.S. Patil, Chemical composition of volatile oil from Citrus limettioides and their inhibition of colon cancer cell proliferation. Industrial Crops and Products, 45, 200–207 (2013). doi:https://doi.org/10.1016/j.indcrop.2012.12.020.
- Y. Zu, H. Yu, L. Liang, et al., Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. Molecules, 15(5), 3200–3210 (2010).
- S. Carnesecchi, K. Langley, F. Exinger, F. Gosse and F. Raul, Geraniol, a component of plant essential oils, sensitizes human colon cancer cells to 5-flfluorouracil treatment. IARC Scientific Publications, 156, 407–409 (2002).
- A. Calcabrini, A. Stringaro, L. Toccacieli, S. Meschini, M. Marra, M. Colone, et al., Terpinen-4-ol, the main component of Melaleuca Colone M, et al. Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the growth of human melanoma cells. Journal of Investigative Dermatology, 122(2), 349–360 (2004). doi:https://doi.org/10.1046/j.0022-202X.2004.22236.x.
- D.D. Deb, G. Parimala, D.S. Saravana and T. Chakraborty, Effect of thymolon peripheral blood mononuclear cell PBMC and acute promyelocytic cancer cell line HL-60. Chemico Biological Interactions, 193(1), 97–106 (2011). doi:https://doi.org/10.1016/j.cbi.2011.05.009.
- S. Jayakumar, A. Madankumar, S. Asokkumar, et al., Potential preventive effect of carvacrol against diethyl-nitrosamine induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry, 360(1–2), 51–60 (2012). doi:https://doi.org/10.1007/s11010-011-1043-7.
- W. Chaouki, D.Y. Leger, B. Liagre, W. Chaouki, D.Y. Leger, B. Liagre, J.-L. Beneytout and M. Hmamouchi, Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundamental & Clinical Pharmacology, 23(5), 549–556 (2009). doi:https://doi.org/10.1111/j.1472-8206.2009.00738.x.
- H. Elshafie, M. Armentano, M. Carmosino, S. Bufo, V. De Feo and I. Camele, Cytotoxic activity of Origanum Vulgare L. on Hepatocellular Carcinoma cell Line HepG2 and evaluation of its biological activity. Molecules, 22(9), 1435. 1–16 (2017). doi:https://doi.org/10.3390/molecules22091435.
- H.S. Elshafie and C. Ippolito, An overview of the biological effects of some Mediterranean essential oils on human health. BioMed Research International, 14, 9268468 (2017). doi:https://doi.org/10.1155/2017/9268468.
- B. Bhattacharjee and J. Chatterjee, Identification of proapoptotic, anti-inflammatory, anti-proliferative, anti-invasive, and antiangiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pacific Journal of Cancer Prevention, 14(6), 3735–3742 (2013). doi:https://doi.org/10.7314/APJCP.2013.14.6.3735.
- M. Valdivieso-Ugarte, C. Gomez-Llorente, J. Plaza-Díaz and Á. Gil, Antimicrobial, antioxidant, and immunomodulatory properties of essential oils: a systematic review. Nutrients, 11(11), E2786 (2019). doi:https://doi.org/10.3390/nu11112786.
- M. D’agostino, N. Tesse, J.P. Frippiat, M. Machouart and A. Debourgogne, Essential oils and their natural active compounds presenting antifungal properties. Molecules, 24(20), 3713 (2019). doi:https://doi.org/10.3390/molecules24203713.
- I. Korona-Glowniak, A. Glowniak-Lipa, L. Agnieszka, B. Tomasz and M. Anna, the in vitro activity of essential oils against Helicobacter Pylori growth and urease activity. Molecules, 25(3), 586 2–15 (2020). doi:https://doi.org/10.3390/molecules25030586.
- P. Knezevic, A.S. Verica, S. Natasa, L. Marija and N. Mimica-Dukic, colorimetric broth microdilution method for assessment of Helicobacter pylori sensitivity to antimicrobial agents. Journal of Pharmaceutical and Biomedical Analysis, 152(15), 271–278 (2018). doi:https://doi.org/10.1016/j.jpba.2018.02.003.
- H.G. Preuss, B. Echard, M. Enig, I. Brook and T.B. Elliott, Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria. Molecular and Cellular Biochemistry, 272(1–2), 29–34 (2005). doi:https://doi.org/10.1007/s11010-005-6604-1.
- G.E. Bergonzelli, D. Donnicola, N. Porta and I.E. Corthésy-Theulaz, Essential oils as components of a diet-based approach to management of helicobacter infection. Antimicrobial Agents and Chemotherapy, 47(10), 3240–3246 (2003). doi:https://doi.org/10.1128/AAC.47.10.3240-3246.2003.
- M. Harmati, E. Gyukity-Sebestyen, G. Dobra, G. Terhes, E. Urban, G. Decsi, N. Mimica-Dukic, M. Lasjak, N. Simin, B. Pap, et al., Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection. Helicobacter, 22(2), e12350, 1–7 (2017). doi:https://doi.org/10.1111/hel.12350.
- M. Zahra, S. Mohammad, B. Mahbubeh, H. Mannan, H.F. Mohammad, G. Mahdi, S. Farideh and S. Parastoo, Protective effect of essential oil of Pistacia atlantica Desf. on peptic ulcer: role of α-pinene. Journal of Traditional Chinese Medicine, 37(1), 57–63 (2017). doi:https://doi.org/10.1016/S0254-6272(17)30027-4.
- M. Ramezani, M. Khaje-Karamoddin and V. Karimi-Fard, Chemical composition and Anti–Helicobacterpylori activity of the essential oil of Pistacia vera. Pharmaceutical Biology, 42(7), 488–490 (2004). doi:https://doi.org/10.3109/13880200490891755.
- E.A. O’Gara, D.J. Maslin, A.M. Nevill and D.J. Hill, The effect of simulated gastric environments on the anti-Helicobacter activity of garlic oil. Journal of Applied Microbiology, 104(5), 1324–1331 (2008). doi:https://doi.org/10.1111/j.1365-2672.2007.03637.x.
- S.D. Moghadam, S.D. Moghadam, F. Ebrahimi, M. Hayatbakhsh, M.J. Zahedi, S. F, M. Hayatbakhsh, S. F and F. Sharififar, In vitro screening of selected Iranian medicinal plants against Helicobacter pylori. International Journal of Green Pharmacy, 5(4), 282–285 (2011).
- B.I. Oakley, P.O. Bessong and R.N. Ndip, Preliminary phytochemical screening and in vitro anti-Helicobacter pylori activity of extracts of the stem bark of Bridelia micrantha (Hochst., Baill., Euphorbiaceae). Molecules, 16(8), 6193–6205 (2011). doi:https://doi.org/10.3390/molecules16086193.
- A.S. Awaad, A.A. Al-Rifai, R.M. El-Meligy, A.M. Alafeefy and M.E. Zain, New activities for isolated compounds from Convolvulus austro-aegyptiacus as Anti-ulcerogenic, Anti-Helicobacter pylori and their mimic synthesis using bio-guided fractionation. Phytotherapy Research, 9(9), 1311–1316 (2015). doi:https://doi.org/10.1002/ptr.5379.
- A.L. Rozza, T.M. Moraes, H. Kushima, A. Tanomoto, M. Marques, T.M. Bauab, C.A. Hiruma-Lima and C.H. Pellizzon, Gastroprotective mechanisms of Citrus lemon (Rutaceae) essential oil and its majority compounds limonene and pinene: involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide, and prostaglandin E2. Chemico-Biological Interactions, 189(1–2), 82–89 (2011). doi:https://doi.org/10.1016/j.cbi.2010.09.031.
- S. Prabuseenivasan, M. Jayakumar and S. Ignacimuthu, In vitro antibacterial activity of some plant essential oils. BMC Complementary and Alternative Medicine, 6(1), 39 (2006). doi:https://doi.org/10.1186/1472-6882-6-39.
- J. Sikkema, J.A.M. De Bont and B. Poolman, Interactions of cyclic hydrocarbons with biological membranes. Journal of Biological Chemistry, 269(11), 8022–8028 (1994). doi:https://doi.org/10.1016/S0021-9258(17)37154-5.
- M. Yousefi, N. Khorshidian and H. Hosseini, Potential application of essential oils for mitigation of Listeria monocytogenes in meat and poultry products. front. Nutr, 7, 577287 (2020). doi:https://doi.org/10.3389/fnut.2020.577287.
- E.J. Veldhuizen, J.L. Tjeerdsma-van Bokhoven, C. Zweijtzer, S.A. Burt and H.P. Haagsman, Structural requirements for the antimicrobial activity of carvacrol. Journal of Agricultural and Food Chemistry, 54(5), 1874–1879 (2006). doi:https://doi.org/10.1021/jf052564y.
- J. Xu, F. Zhou, B.P. Ji, R.S. Pei and N. Xu, The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Letters in Applied Microbiology, 47(3), 174–179 (2008). doi:https://doi.org/10.1111/j.1472-765X.2008.02407.x.
- T. Falsafifi, P. Moradi, M. Mahboubi, E. Rahimi, H. Momtaz and B. Hamedi, Chemical composition and anti-Helicobacter pylori effect of Satureja bachtiarica Bunge essential oil. Phytomedicine, 22(1), 173–177 (2015). doi:https://doi.org/10.1016/j.phymed.2014.11.012.
- G.R. Rudramurthy, M.K. Swamy, U.R. Sinniah and A. Ghasemzadeh, Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules, 21(7), 836 (2016). doi:https://doi.org/10.3390/molecules21070836.
- H.A. Ben, H.N. Ben and S. Abdelkafi, Essential oil from Artemisia phaeolepis: chemical composition and antimicrobial activities. Journal of Oleo Science, 62(12), 973–980 (2013). doi:https://doi.org/10.5650/jos.62.973.
- G. Kiskó and S. Roller, Carvacrol and p-cymene inactivate Escherichia coli O157:H7 in apple juice. BMC Microbiology. 5(36), 2005. doi:https://doi.org/10.1186/1471-2180-5-36.
- Y.F. Xu, D.W. Lian, Y.Q. Chen, Y.F. Cai, Y.F. Zheng, P.L. Fan, W.K. Ren, L.J. Fu, Y.C. Li, J.H. Xie, et al., In vitro and in vivo antibacterial activities of patchouli alcohol, a naturally occurring tricyclic sesquiterpene, against Helicobacter pylori infection. Antimicrobial Agents and Chemotherapy, 61(6), e00122–17 (2017). doi:https://doi.org/10.1128/AAC.00122-17.
- L.K. Chaudhari, B.A. Jawale, S. Sharma, H. Sharma, C.D. Kumar and P.A. Kulkarni, Antimicrobial activity of commercially available essential oils against Streptococcus mutans. The Journal of Contemporary Dental Practice, 13(1), 71–74 (2012). doi:https://doi.org/10.5005/jp-journals-10024-1098.
- Y. Takao, I. Kuriyama, T. Yamada, H. Mizoguchi, H. Yoshida and Y. Mizushina, Antifungal properties of Japanese cedar essential oil from waste wood chips made from used sake barrels. Molecular Medicine Reports, 5(5), 1163–1168 (2012). doi:https://doi.org/10.3892/mmr.2012.821.
- H.J. Woo, J.Y. Yang, M.H. Lee, H.W. Kim, H.J. Kwon, M. Park, K. Sung-kyu, P. So-Young, K. Sa-Hyun and K. Jong-Bae, Inhibitory effects of β-Caryophyllene on Helicobacter pylori infection in vitro and in vivo. International Journal of Molecular Sciences, 21(3), 1008 (2020). doi:https://doi.org/10.3390/ijms21031008.
- M. Arputha, P. Selvamani and S. Latha, In-Vitro antimicrobial evaluation of extracts, oil and fractionated geraniol of Cymbopogan citratus-an aromatic grass. International Journal of Environmental Science and Technology, 3(1), 583–590 (2012).
- F. Eftekhar, F. Nariman, M. Yousefzadic, H. Javad and N. E, Samad Anti- Helicobacter pylori activity and essential oil composition of Thymus caramanicus from Iran. Natural Product Communications, 4(8), 139–142 (2009). doi:https://doi.org/10.1177/1934578X0900400825.
- F. Matongo and U.U. Nwodo, In vitro assessment of Helicobacter pylori urease inhibition by honey fractions. Archives of Medical Research, 45(7), 540–546 (2014). doi:https://doi.org/10.1016/j.arcmed.2014.09.001.
- S.A. Tariq, M.N.O. Ahmad, M.I. Choudhary, M.I. Choudhary, W. Ahmad and M. Ahmad, Urease inhibitors from Indigofera gerardiana Wall. Journal of Enzyme Inhibition and Medicinal Chemistry, 26(4), 480–484 (2011). doi:https://doi.org/10.3109/14756366.2010.528415.
- M. Amin, F. Anwar, F. Naz, T. Mehmood and N. Saari, Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules, 18(2), 2135–2149 (2013). doi:https://doi.org/10.3390/molecules18022135.
- E. Pastene, H. Speisky, A. García, J. Moreno, M. Troncoso and G. Figueroa, In vitro and in vivo effects of apple peel polyphenols against Helicobacter pylori. Journal of Agricultural and Food Chemistry, 58(12), 7172–7179 (2010). doi:https://doi.org/10.1021/jf100274g.
- E. Pastene, M. Troncoso, G. Figueroa, J. Alarcón and H. Speisky, Association between polymerization degree of apple peel polyphenols and inhibition of Helicobacter pylori Urease. Journal of Agricultural and Food Chemistry, 57(2), 416–424 (2009). doi:https://doi.org/10.1021/jf8025698.
- Y.T. Lin, Y.I. Kwon, R.G. Labbe and K. Shetty, Inhibition of Helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies. Applied and Environmental Microbiology, 71, 8558–8564 (2005).
- A. Quílez, B. Berenguer, G. Gilardoni, C. Souccar, S. de Mendonça, L.F. Oliveira, M.J. Martín-Calero and G. Vidari, Anti-secretory, anti-inflammatory and anti-Helicobacter pylori activities of several fractions isolated from Piper carpunya Ruiz & Pav. Journal of Ethnopharmacology, 128(3), 583–589 (2010). doi:https://doi.org/10.1016/j.jep.2010.01.060.
- M.S. de Oliveira, M.A. Marcos, A.R.S. Marielba de Los, C.S.P. Flávia, W.F.B. Fernanda, M.B.C. Vânia, M. C.Renato, R.O.U. Glides, et al., Potential of medicinal use of essential oils from aromatic plants 5th. (2018). https://www.intechopen.com/chapters/61636
- G. Nieto, Biological activities of three essential oils of the Lamiaceae family. Medicines, 4(3), 63 (2017). doi:https://doi.org/10.3390/medicines4030063.
- W. Luo, D. Zhiyun, Z. Yating, L. Xiaoxin, H. Guomeng, et al., Phytochemical composition and bioactivities of essential oils from six Lamiaceae species. Industrial Crops and Products, 133, 357–364 (2019). doi:https://doi.org/10.1016/j.indcrop.2019.03.025.
- X. Chen, GC-MS analysis and bioactivity of essential oil from Scutellaria hainanensis. Chinese Journal of Tropical Agriculture, 36, 93–97 (2016).
- W. Sun, S. Wang, W. Zhao, C. Wu, S. Guo, et al., Chemical constituents and biological research on plants in the genus Curcuma. Critical Reviews in Food Science and Nutrition, 57(7), 1451–1523 (2017). doi:https://doi.org/10.1080/10408398.2016.1176554.
- S. Tariq, S. Wani, W. Rasool, K. Shafi, M.A. Bhat, et al., A comprehensive review of the antibacterial, antifungal, and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens. Microbial Pathogenesis, 134, 01–20 (2019).
- K. Lee, J.H. Lee, S.I. Kim, M.H. Cho and J. Lee, Anti-biofilm,anti-hemolysis, and anti-virulence activities of black pepper, cananga, myrrh oils, and nerolidol against Staphylococcus aureus. Applied Microbiology and Biotechnology, 98(22), 9447–9457 (2014). doi:https://doi.org/10.1007/s00253-014-5903-4.
- R. Irkin and M. Korukluoglu, Growth inhibition of pathogenic bacteria and some yeasts by selected essential oils and survival of L. monocytogenes and C. albicans in apple–carrot juice. Foodborne Pathogens and Disease, 6(3), 387–394 (2009). doi:https://doi.org/10.1089/fpd.2008.0195.
- J.A. Gray, P.S. Chandry, M. Kaur, C. Kocharunchitt, J.P. Bowman and E.M. Fox, Novel biocontrol methods for Listeria monocytogenes biofilms in food production facilities. Frontiers in Microbiology, 9, 605 (2018). doi:https://doi.org/10.3389/fmicb.2018.00605.
- K. Haddi, L. Faroni and E.E. Oliveira, Cinnamon oil, in green pesticides handbook: essential oils for pest control. CRC Press, 117–150 (2017).
- J.M. Barbosa-Filho, A.A. Alencar, X.P. Nunes, A.C. Andrade Tomaz, J.G. Sena-Filho, et al., Sources of alpha-, beta-, gamma-, delta-and epsilon-carotenes: a twentieth century review. Revista Brasileira de Farmacognosia, 18(1), 135–154 (2008). doi:https://doi.org/10.1590/S0102-695X2008000100023.
- O.R. Asuquo, C.E. Fischer, O.E. Mesembe, A.O. Igiri and J.I. Ekom, Comparative study of aqueous and ethanolic leaf extracts of Spondias mombin on neurobehaviour in male rats. IOSR Journal of Pharmacy and Biological Sciences, 5(2), 29–35 (2013). doi:https://doi.org/10.9790/3008-0522935.
- Y. Millet, J. Jouglard, M.D. Steinmetz, P. Tognetti, P.Joanny and J. Arditti, Toxicity of some essential plant oils. Clinical and experimental study. Clinical Toxicology, 18(12), 1485–1498 (1981). doi:https://doi.org/10.3109/15563658108990357.
- A. Prashar, I.C. Locke and C.S. Evan, Cytotoxicity of lavender oil and its major components to human skin cells. Cell Proliferation, 37(3), 221 (2004). doi:https://doi.org/10.1111/j.1365-2184.2004.00307.x.
- F. Bakkali, S. Averbeck, D. Averbeck and M. Idaomar, Biological effects of essential oils – a review. Food and Chemical Toxicology, 46(2), 446–475 (2008). doi:https://doi.org/10.1016/j.fct.2007.09.106.
- D. Bilsland and A. Strong, Allergic contact dermatitis from the essential oil of French marigold (Tagetes patula) in an aromatherapist. Contact Dermatitis, 23(1), 55–56 (1990). doi:https://doi.org/10.1111/j.1600-0536.1990.tb00091.x.
- R. Tisserand and T. Balance, Essential Oil Safety: A Guide for Health Professionals. Churchill Livingstone, Edinburgh (1995).
- T. Burfifield, Safety of essential oils. International Journal of Aromatherapy, 10(1–2), 16–29 (2000). doi:https://doi.org/10.1016/S0962-4562(00)80005-3.
- M. Schaller and H.C. Korting, Allergic airborne contact dermatitis from essential oils used in aromatherapy. Clinical and Experimental Dermatology, 20(2), 143–145 (1995). doi:https://doi.org/10.1111/j.1365-2230.1995.tb02719.x.
- D.V. Henley, N. Lipson, K.S. Korach and C.A. Bloch, Prepubertal gynecomastia linked to lavender and tea tree oils. New England Journal of Medicine, 356(5), 479–485 (2007). doi:https://doi.org/10.1056/NEJMoa064725.